Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Chimiothérapie
Extract
A phase 3 randomized open-label study of neratinib versus lapatinib plus capecitabine for the treatment of ERBB-2 positive locally advanced or metastatic breast cancer.
Scientific Abstract
en cours d'intégration;